For years, scientists at the Fraunhofer USA Center for Molecular Biotechnology have been infusing plants with genes to produce proteins that could one day immunize people from diseases such as ...

The Fraunhofer Center for Molecular Biotechnology ("CMB") in Newark ... scalable "factory" that uses natural (non-genetically-modified) green plants to efficiently produce large quantities of vaccines ...

The biotech also cites Fraunhofer's website, which advertises its ability to develop biopharmaceuticals using "a proprietary plant-based expression platform." And it notes a 2014 annual report ...

Fraunhofer Center for Molecular Biotechnology in Newark ... The Center conducts research in the area of plant biotechnology, utilizing new, cutting edge technologies to assist the diagnosis, ...

About Fraunhofer USA Center for Molecular Biotechnology ... The Center conducts research in the area of plant biotechnology, utilizing new, cutting edge technologies applicable to the diagnosis ...

Plant-based product developer iBio, which announced just before Labor Day a deal with GE Healthcare and the Fraunhofer Center for Molecular Biotechnology to develop biopharma and vaccine ...

Plants cannot thrive without ... The researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart, Germany are working at alternatives.

Partners say their plant-based technology platform was validated. Integrated BioPharma (INB) and the Fraunhofer USA Center for Molecular Biotechnology (FCMB) report the successful validation of ...

The pilot plant is part of the ETAMAX ... Ursula Schließmann, head of department at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB). Because the microorganisms ...